Other capital market information | 15 September 2025 14:39
Fresenius Medical Care AG : Release of a capital market information
|
Fresenius Medical Care AG
/ Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014
Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from September 8, 2025 to September 12, 2025 (each inclusive), 130,260 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:
A total of 2,978,062 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/ .
15.09.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
| Language: | English |
| Company: | Fresenius Medical Care AG |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | EQS News Service |
|
|
2197608 15.09.2025 CET/CEST